# Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use

> **NCT00691171** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5234 (actual)

## Conditions studied

- GERD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00691171
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 5234 (ACTUAL)
- **Last updated:** 2015-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691171, "Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00691171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*